Lannett enters into distribution deal for ADHD drug

Lannett Co. Inc., two months after announcing the loss of a major distribution deal, said Monday it has entered into an agreement with Adare Pharmaceuticals Inc. to be the exclusive U.S. distributor of dexmethylphenidate hydrochloride extended release capsules. Dexmethylphenidate hydrochloride is a stimulant used to treat attention deficit hyperactivity disorder. The drug has an estimated market value of about $620 million according to IMS, a pharmaceutical data company. Under the agreement, Lannett…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news